GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagittarius Life Science Corp (ROCO:3205) » Definitions » Research & Development

Sagittarius Life Science (ROCO:3205) Research & Development : NT$21.8 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Sagittarius Life Science Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sagittarius Life Science's Research & Development for the three months ended in Dec. 2023 was NT$5.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was NT$21.8 Mil.

Sagittarius Life Science Research & Development Historical Data

The historical data trend for Sagittarius Life Science's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sagittarius Life Science Research & Development Chart

Sagittarius Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.58 24.86 31.58 22.69 21.83

Sagittarius Life Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.71 6.45 4.49 5.50 5.38

Sagittarius Life Science Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$21.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagittarius Life Science  (ROCO:3205) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sagittarius Life Science Research & Development Related Terms

Thank you for viewing the detailed overview of Sagittarius Life Science's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sagittarius Life Science (ROCO:3205) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sagittarius Life Science Corp (ROCO:3205) » Definitions » Research & Development
Comparable Companies
ROCO:6827 ROCO:6709 ROCO:4195 ROCO:4186 ROCO:6850 ROCO:6872 ROCO:6810 ROCO:6610 ROCO:4192 ROCO:6652 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 10-6th Floor, Nangang District, Taipei, TWN
Website
http://www.naturalbiokey.com
Sagittarius Life Science Corp is a Taiwan based company engaged in operating as a biotechnology and pharmaceutical company. Its business activity is to develop Chinese herbal medicines and supplements for the treatment of bone fractures, osteoporosis, wound healing and skin care.

Sagittarius Life Science (ROCO:3205) Headlines

No Headlines